270 related articles for article (PubMed ID: 28420434)
21. CD73-Positive Cell Spheroid Transplantation Attenuates Colonic Atrophy.
Hisamatsu D; Itakura N; Mabuchi Y; Ozaki R; Suto EG; Naraoka Y; Ikeda A; Ito L; Akazawa C
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986706
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease.
Qiao Y; Tang X; Liu Z; Ocansey DKW; Zhou M; Shang A; Mao F
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794176
[TBL] [Abstract][Full Text] [Related]
23. Current status of diagnosis and Mesenchymal stem cells therapy for acute pancreatitis.
Munir F; Jamshed MB; Shahid N; Muhammad SA; Ghanem NB; Qiyu Z
Physiol Rep; 2019 Nov; 7(21):e14170. PubMed ID: 31691545
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Effect of Mesenchymal Stem Cells in Ulcerative Colitis: A Review on Achievements and Challenges.
Hosseini-Asl SK; Mehrabani D; Karimi-Busheri F
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33287220
[TBL] [Abstract][Full Text] [Related]
25. Oxidative Stress and Neural Dysfunction in Gastrointestinal Diseases: Can Stem Cells Offer a Solution?
Stavely R; Ott LC; Sahakian L; Rashidi N; Sakkal S; Nurgali K
Stem Cells Transl Med; 2023 Dec; 12(12):801-810. PubMed ID: 37774373
[TBL] [Abstract][Full Text] [Related]
26. Global hypoxia-ischemia induced inflammation and structural changes in the preterm ovine gut which were not ameliorated by mesenchymal stem cell treatment.
Nikiforou M; Willburger C; de Jong AE; Kloosterboer N; Jellema RK; Ophelders DRMG; Steinbusch HWM; Kramer BW; Wolfs T
Mol Med; 2016 Sep; 22():244-257. PubMed ID: 27257938
[TBL] [Abstract][Full Text] [Related]
27. Wogonin preconditioning of MSCs improved their therapeutic efficiency for colitis through promoting glycolysis.
Wu M; Li C; Zhou X; Wu Z; Feng J; Guo X; Fang R; Lian Q; Pan M; Lai X; Peng Y
Inflammopharmacology; 2024 May; ():. PubMed ID: 38753221
[TBL] [Abstract][Full Text] [Related]
28. Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device.
Mairal A; Mehrotra S; Kumar A; Maiwal R; Marsal J; Kumar A
ACS Appl Mater Interfaces; 2024 Feb; 16(5):5382-5400. PubMed ID: 38266010
[TBL] [Abstract][Full Text] [Related]
29. A Comprehensive Exploration of Therapeutic Strategies in Inflammatory Bowel Diseases: Insights from Human and Animal Studies.
Dias IE; Dias IR; Franchi-Mendes T; Viegas CA; Carvalho PP
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672091
[TBL] [Abstract][Full Text] [Related]
30. Long-term and low dose oral malathion exposure causes morphophysiological changes in the colon of rats.
Pupim ACE; Basso CR; Machado CCA; Watanabe PS; Fernandes GSA; ErthalL RP; Sodré GBC; Guarnier FA; Simão ANC; Araújo EJA
Life Sci; 2023 Aug; 327():121840. PubMed ID: 37290667
[TBL] [Abstract][Full Text] [Related]
31. Chemically-induced trout model of acute intestinal inflammation using TNBS.
Horn ME; Segner H; Brinkmann M; Machtaler S
Fish Shellfish Immunol Rep; 2023 Dec; 4():100073. PubMed ID: 36605611
[TBL] [Abstract][Full Text] [Related]
32. Leveraging stem cells to combat hepatitis: a comprehensive review of recent studies.
Raoufinia R; Arabnezhad A; Keyhanvar N; Abdyazdani N; Saburi E; Naseri N; Niazi F; Niazi F; Namdar AB; Rahimi HR
Mol Biol Rep; 2024 Mar; 51(1):459. PubMed ID: 38551743
[TBL] [Abstract][Full Text] [Related]
33. The Enteric Nervous System: A Link Between Stress and Colitis.
Reed D
Gastroenterology; 2023 Nov; 165(5):1304. PubMed ID: 37393024
[No Abstract] [Full Text] [Related]
34. Intravenous mesenchymal stromal cell therapy for inflammatory bowel disease: Lessons from the acute graft versus host disease experience.
Conklin LS; Hanley PJ; Galipeau J; Barrett J; Bollard CM
Cytotherapy; 2017 Jun; 19(6):655-667. PubMed ID: 28433516
[TBL] [Abstract][Full Text] [Related]
35. Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.
Ananthakrishnan AN; Luo C; Yajnik V; Khalili H; Garber JJ; Stevens BW; Cleland T; Xavier RJ
Cell Host Microbe; 2017 May; 21(5):603-610.e3. PubMed ID: 28494241
[TBL] [Abstract][Full Text] [Related]
36. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ; Su C; Sands BE; D'Haens GR; Vermeire S; Schreiber S; Danese S; Feagan BG; Reinisch W; Niezychowski W; Friedman G; Lawendy N; Yu D; Woodworth D; Mukherjee A; Zhang H; Healey P; Panés J;
N Engl J Med; 2017 May; 376(18):1723-1736. PubMed ID: 28467869
[TBL] [Abstract][Full Text] [Related]
37. Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?
Lanthier N; Lin-Marq N; Rubbia-Brandt L; Clément S; Goossens N; Spahr L
Stem Cell Res Ther; 2017 Apr; 8(1):88. PubMed ID: 28420441
[TBL] [Abstract][Full Text] [Related]
38. Impact of chemotherapy on gastrointestinal functions and the enteric nervous system.
Escalante J; McQuade RM; Stojanovska V; Nurgali K
Maturitas; 2017 Nov; 105():23-29. PubMed ID: 28545907
[TBL] [Abstract][Full Text] [Related]
39. Cognitive behavioural therapy for the management of inflammatory bowel disease-fatigue with a nested qualitative element: study protocol for a randomised controlled trial.
Artom M; Czuber-Dochan W; Sturt J; Norton C
Trials; 2017 May; 18(1):213. PubMed ID: 28490349
[TBL] [Abstract][Full Text] [Related]
40. Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence.
Nikolaus S; Schreiber S; Siegmund B; Bokemeyer B; Bästlein E; Bachmann O; Görlich D; Hofmann U; Schwab M; Kruis W
J Crohns Colitis; 2017 Sep; 11(9):1052-1062. PubMed ID: 28486634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
